Replies to post #206097 on NorthWest Biotherapeutics Inc (NWBO)

[JerryCampbell]

You are correct, and also missing something.

Correct that all of the existing A and B Preferred was forced to convert.

What you missed is the footnote about Linda Powers' loan, which shows how she can become the sole Preferred shareholder anytime she wants:

The principal and interest of the Convertible Notes are convertible into Series B Preferred Stock at conversion price of $2.30 per share, and each share of Series B Preferred Stock is convertible into 10 shares of common stock. Additionally, the Convertible Notes carry Class D-2 Warrants, with half of the Class D-2 Warrants due and issuable when the loan was provided, and half of the Class D-2 Warrants due on a proportional basis in the event of conversion of some or all of the Note. The Class D-2 Warrants have five-year term.